Singapore and Dubai – 12 October 2026 – To support future expansion plans, Global Biopolymers Industries (GBI) today announced a strategic realignment of its biopolymers business. Emirates Biotech will focus on building and operating a world-scale PLA production plant in the UAE while Embio Biotech will serve as the global commercial home of the Embio PLA product range.
Headquartered in Dubai and led by François de Bie, Embio Biotech will be responsible for the global marketing and sales of the Embio PLA product range, working with converters, brands and distributors to support adoption across international markets.
Emirates Biotech, under the leadership of Viktoria de Simone, will focus on building and operating its world-scale PLA production facility in the United Arab Emirates, creating advanced local manufacturing capacity and a regional source of plant-based polymers.
Engineering, technology, and operations expertise will be consolidated at GBI Management Services and will be led by Marc Verbruggen.
“This realignment positions us for international growth,” said Dorus Everwijn, President of GBI. “Dedicated hubs for sales, engineering and production give each organisation a clear mandate and allow for greater focus.”
“Demand for sustainable materials is growing across markets, and customers need both reliable supply and practical support to make the transition,” said François de Bie. “Embio Biotech will be the commercial home of Embio PLA, giving converters, brands and distributors one partner for the material and the expertise needed to use it.”
“The UAE is building a globally competitive, sustainable industrial base, and advanced local manufacturing has an important role to play,” said Viktoria de Simone of Emirates Biotech. “Our focus is to build a world-scale PLA plant that strengthens regional access to plant-based polymers and creates advanced manufacturing capacity in the UAE, in line with Operation 300bn.”
-ENDS-
About Global Biopolymers Industries (GBI)
GBI accelerates the world’s transition to sustainable materials through visionary investments, scaling biopolymers technologies and cross-border collaboration. Guided by responsibility, we build enduring value by merging environmental progress with economic performance – creating growth that benefits people, businesses and planet alike. The development of PLA biopolymers is one of the most important innovations in the fight to tackle global pollution and climate change, and GBI is at the heart of this transformational agenda.
GBI is headquartered in Singapore with an established presence in Dubai, United Arab Emirates.
http://www.gb.industries
About Emirates Biotech
Emirates Biotech is a pioneer producer of sustainable substitutes for conventional plastics. Proudly based in the UAE, we are building a world-scale biopolymer production platform in the region, combining advanced technology with a strong focus on quality, sustainability and the principles of the circular economy.
Our PLA biopolymers are renewable, recyclable, compostable and offer a practical route towards reducing dependence on fossil-based plastics. Our ambition is simple: to accelerate the transition to a circular, biobased society, making our planet a better place for future generations.
Emirates Biotech is a Global Biopolymers Industries company based in the United Arab Emirates.
www.emiratesbiotech.com
About Embio Biotech
Embio Biotech is a global marketing and sales platform for PLA, and the exclusive commercial home of Embio PLA biopolymers. Our PLA biopolymers are renewable, recyclable, biodegradable and directly relevant to the goals of a circular economy.
We work closely with our partners across the value chain, supporting application development, processing, regulatory compliance and sustainable end-of-life solutions. We help businesses navigate the evolving landscape of plastics regulation and sustainability and accelerate the adoption of biobased and circular materials.
Embio Biotech is a Global Biopolymers Industries company and is headquartered in Dubai, United Arab Emirates.
http://www.embio-biotech.com
About Embio PLA
Embio PLA (PolyLactic Acid) biopolymers are derived from plants that absorb CO2 from our atmosphere, reducing the carbon footprint by over 75% compared to traditional plastics. Embio PLA biopolymers can be recycled like any other polymer or broken down naturally, helping to cut down on plastic pollution.
The Embio PLA portfolio spans commercial grades for extrusion, injection moulding, spinning and 3D printing, serving applications including packaging, food service ware, appliances, textiles, non-wovens and 3D printing. Embio grades are designed to meet the technical requirements of its target markets and at the same time comply with recognised industrial composting and food contact standards.
http://www.embio-biotech.com
Media Contact:
Veronika Wegner, vw@gb.industries
François de Bie, fdebie@embio-biotech.com